, originally isolated from hog small intestinal mucosa, has been shown to cause small intestinal secretion. More recently, this peptide has been identified in the plasma and tumors of patients with the so-called "pancreatic cholera" syndrome. In order to explore the possible role of VIP in the pathogenesis of this syndrome, we examined the effects of this peptide and other hormones on the cyclic AMP levels, adenylate cyclase activity, and ion transport in in vitro preparations of ileal mucosa. In rabbit ileal mucosa, VIP (20 usg/ml) caused a prompt fivefold increase in cyclic AMP level, whereas nine other hormones, which have been postulated to cause intestinal secretion, failed to exert such an effect. Pentagastrin and glucagon also failed to increase cyclic AMP levels in canine ileal mucosa. An increase in mucosal cyclic AMP levels was observed at a VIP concentration of 0.1 4g/ml and appeared to be nearly maximal at 2.0 Ag/ml. VIP (100 sg/ml) stimulated adenylate cyclase activity in a membrane preparation from rabbit ileal mucosa. Secretin (6.0 X 10-M) failed to do so. When added to the serosal side of isolated rabbit ileal mucosa clamped in an Ussing chamber, VIP (2 ug/ml) increased short-circuit current (SCC) and caused net secretion of both C1 and Na. Net Cl secretion exceeded net Na secretion. These effects of VIP on mucosal cyclic AMP metabolism and ion transport are similar to those observed with cholera enterotoxin and certain prostaglandins. VIP was also tested with normal human Dr. Kimberg is the recipient of a Research Career Development Award, AM-19377. 
INTRODUCTION
Vasoactive intestinal peptide (VIP)' was originally isolated from the small intestine of hogs by Said and Mutt (1, 2) , and the synthesis of this octacosapeptide has recently been reported by Bodanszky, Klausner, and Said (3) . This peptide, related in structure to secretin, glucagon, and gastric inhibitory peptide (GIP), has potent and diverse biological activity. Thus, it has been shown to cause vasodilatation, lowering of arterial blood pressure, increased cardiac output, enhanced myocardial contractility, hyperventilation, smooth muscle relaxation, pancreatic secretion, and glycogenolysis with associated hyperglycemia (1) (2) (3) (4) (5) (6) . Of special interest with regard to the role which VIP may play in small intestinal function are the observations of Barbezat and Grossman (7) and of Bloom, Polak, and Pearse (8) . The former workers (7) demonstrated that intravenously administered VIP caused a striking net secretory response in the 1 Abbreviations used in this paper: GIP, gastric inhibitory peptide; KRB, Krebs-Ringer bicarbonate solution; SCC, short-circuit current; VIP, vasoactive intestinal peptide. (8) reported elevated plasma levels and/or a high tumor content of VIP by specific radioimmunoassay in six patients with watery diarrhea associated with the so-called pancreatic cholera syndrome (9) (10) (11) (12) (13) .
Both cholera enterotoxin and certain prostaglandins stimulate adenylate cyclase in small intestinal mucosal cells (14, 15) , which thus increases the cellular content of cyclic AMP (14, 16, 17) . Furthermore, there is now good reason to believe that the diarrhea seen in cholera (18) , in association with the administration of prostaglandins (19) (20) (21) or in patients with certain prostaglandin-secreting tumors (22, 23) , is due to cyclic AMPmediated stimulation of water and electrolyte secretion, inhibition of active absorption thus unmasking an active secretory process, or some combination of both events (24) (25) (26) (27) (28) (29) . In view of the known effects of VIP on small intestinal secretion (7) , its recent implication as a potential secretagogue in the pancreatic cholera syndrome (8) , and the recent demonstration that this peptide can stimulate adenylate cyclase activity in liver (30) and in fat cell membranes (30, 31) , the present studies were undertaken to examine the effects of VIP and certain other hormones on intestinal cyclic AMP metabolism and ion transport in isolated rabbit and dog ileum. In addition, the effects of VIP on human mucosa obtained from one patient were also studied.
METHODS
Cyclic AMP ineasuirenmcnts. New Zealand white male rabbits (2-3.5 kg) and male mongrel dogs (10-12 kg) were used in the present study. Rabbits were sacrificed by a blow to the neck, while the dogs were anesthetized with intravenous pentobarbital, intubated, and then maintained in stage IV anesthesia with halothane until the end of the procedure at which time they too were sacrificed. The terminal ileum was quickly removed, opened longitudinally, and rinsed in ice-cold Krebs-Ringer bicarbonate solution (KRB) gassed with 95% 02-5% C02, as previously described (17 Gilman (32) and modified as previously described (17) . Each hormone was tested in vitro in this manner with rabbit ileal mucosa. In addition, gastrin, glucagon, and the combination of the two were tested with canine ileal mucosa.
Adenylate cyclase assay. Membranes were prepared from a homogenate of ileal mucosa as previously described (14) . added to each tube. The reaction was terminated by immersing each tube in a boiling water bath for 3 min, and the incubation medium was then passed over a 0.5 X 3.0-cm column containing Dowex 50 XV X 4 resin (Dow Chemical Co., Midland, Mich.), hydrogen form, 200-400 mesh (Calbiochem, San Diego, Calif.). Subsequent steps have been previously described (14) . All assays were performed in triplicate.
Ma[easuireinenits of shiort-circuit current (SCC) and iou fluxes. 20-30-cm segments of distal rabbit ileum were quickly excised, opened longitudinally, and rinsed in KRB. Four 1-2-cm sections were stripped of muscularis and mounted as flat sheets in Ussing chambers as previously described (35) . Electric potential difference, SCC, and DC conductance were monitored as previously described (35) . Unidirectional steady state mucosa-to-serosa and serosa-tomucosa fluxes of Na and Cl were determined on paired tissues by using 22Na and 'Cl (both New England Nuclear). In earlier experiments, Na fluxes alone were determined; in later experiments, Na and Cl fluxes were determined simultaneously. Radioisotopes were added 30 min after mounting tissues. 20 min thereafter, VIP (2 ug/ml) was added to the serosal reservoirs of one pair of tissues, the other pair served as control. Tissues were then maintained in the short-circuited state, except for occasional measurements of open circuit potential difference. Fluxes were calculated as previously described (35) from reservoir samples taken at 10-min intervals for 40 min. Results for the three flux periods (10-40 min post-VIP) were then averaged. In some experiments, after the final sample had been taken, theophylline (5 prmol/ml) was added to the serosal reservoirs, and the resulting changes in SCC were recorded.
Studies on humian ilcum. Distal ileum was removed from near the proximal resection margin of a 50-cm segment of terminal ileum obtained from a 36-yr-old female patient with regional enteritis involving terminal ileum. The ileum thus obtained was kept in ice-cold saline until ready for incubation (about 20 min). In order to determine the effect of VIP on cyclic AMP level, mucosa was separated from the underlying muscle, and segments were incubated in Erlenmeyer flasks exactly as described above for rabbit ileum. Three segments of tissue were incubated in each of four flasks and, after a 40-min preincubation period, VIP (2 uLg/ ml) was added to two flasks. 10 min later all tissues were removed, and cyclic AMP levels were determined.
Sheets of mucosa, removed by scraping with the edge of a glass microscope slide, were mounted in three Ussing chambers and bathed on both sides wvith 10 ml of KRB.
Electric potential difference, resistance, and SCC were determined as previously described (35) . Additions of VIP and theophylline were made to two of the three chambers 50-90 min after mounting the tissues. Glucose (10 kmol/ml) was added to the luminal bathing solution of all three chambers about 2 h after mounting. Glucose produced a rapid increase in SCC (mean increment, 107 ,uA/cmr; range 93-128) which indicated that the mechanism for glucose-coupled Na transport was normal in the mucosal sheets used for these experiments (36 (Fig. 1) . Thus, in the presence of 20 gg of VIP/ml, there was a fivefold increase in cyclic AMP levels at 2, 5, and 10 min (P < 0.05), with a gradual return towards control values during the ensuing 30 min. Neither the 20-nor 40-min cyclic AMP levels in the presence of VIP are significantly different from the corresponding control levels. Furthermore, the 40-min levels in the presence of VIP are lower than those at 5 min (P < 0.05) and 10 min (P < 0.02). The large standard errors in the presence of VIP are probably related to variations in the tissues from the animals used in the five separate experiments. Table I demonstrates the results of three experiments in which the effects of varying concentrations of VIP on rabbit ileal mucosal cyclic AMP levels were assessed after a 5-min incubation. An effect was present at 0.1 /Lg/ml, and the effect was nearly maximal at 2.0 Ag/ml.
A number of hormones which have been found to cause small intestinal secretion, which have been suggested as potential secertagogues in the pancreatic cholera syndrome or which are known to elevate cyclic AMP levels in nonintestinal tissues failed to increase the level of this nucleotide in ileal mucosa (Table II) .
Neither glucagon nor pentagastrin, alone or in combination, led to a change in cyclic AMP levels in rabbit ileal mucosa after 5 and 10 min of incubation. Since Barbezat and Grossman (7, 37, 38) have shown that these peptides, and more especially the two combined (38) , are effective in inducing a net secretory state in canine small intestine in vivo, the effects of these hormones on mucosal cyclic AMIP metabolism was also assessed with material from this speices. Once again, individually or in combination, glucagon and pentagastrin failed to alter cyclic AMP levels measured after 1, 5, and 10 min of incubation (Table III) .
Effects of VIP and secretin on adenylate cyclase activity. VIP and secretin were added to membranes prepared from rabbit ileum. As noted in Fig. 2 stimulation of adenylate cyclase (P < 0.05), and a near maximal effect was obtained at a concentration of 5.0 Ag/ml. These results are consistent with those in Table I in which the effects of varying concentrations of VIP on ileal cyclic AMP levels are reported.
In two separate groups of experiments, the effects on cyclase activity of VIP, secretin, and NaF were compared (Table IV) . Whereas VIP doubled the base-line adenylate cyclase activity (P <0.01), secretin was ineffective. Cyclase activity in the presence of 102 M NaF Fig. 3 . After addition of the peptide (2 ihg/ml) to the serosal reservoir, SCC increased rapidly, reaching a peak in about 1 min. The SCC declined slowly thereafter but remained significantly greater than the control level for 30 min (P < 0.05). Addition of theophylline 40 min after VIP caused a considerably smaller increase in SCC in the VIP-treated tissues than in controls (P < 0.01). The SCC response to VIP is similar to that previously observed for cyclic AMP (39) and the prostaglandins (29) . Blunting of the SCC response to theophylline has previously been noted in studies with cholera toxin (24) and prostaglandins (14) .
Effects of VIP on Na and Cl fluxes across shortcircuited ileal mucosa are shown in Table V . VIP increased SCC and decreased net Na and Cl fluxes, causing net secretory fluxes of 1.2 and 3.8 iceq/h cm', respectively. The changes in both net fluxes were associated with reductions in the mucosa-to-serosa unidirectional fluxes. The serosa-to-mucosa unidirectional fluxes did not change significantly. The magnitudes of net flux changes produced by VIP are similar to those previously observed in this laboratory for cyclic AMP (39), theophylline (39), and cholera enterotoxin (24) . The data in Table V also indicate that VIP did not significantly increase residual ion flux (average SCC -net Na flux + net Cl flux), which averaged 1.4 Aeq/h cm' in controls and 2.0 in VIP-treated tissues. The residual flux has been shown to be an approximate measure of net HCO5 secretion in the ileum (40) . In this respect also, the present results for VIP are similar to those previously reported for cyclic AMP (39), theophylline (39), dibutyryl cyclic AMP (40) , and cholera enterotoxin (24) .
Effects of VIP on cyclic AMP level and SCC of human ileal mucosa. In order to examine the effect of VIP on human small intestine, normal distal ileum was obtained from the operating room, and ileal mucosa was incubated in vitro as described in Methods. Cyclic AMP levels (mean±l SEM) for six VIP-treated and six control tissues (all from the same patient) were 23.6±2.2 and 5.1±0.36 pmol/mg protein, respectively. Thus, VIP produced a fivefold increase in cyclic AMP (P < 0.001) within 10 min of addition.
As shown in Fig. 4 , addition of VIP (2 Pg/ml) to the serosal bathing solution produced a 62 sA/cm' increase in SCC, which was almost identical in magnitude to that produced by addition of theophylline to another chamber (64 IA/cm'). (41) (42) (43) , gastrin (7, 41, 44, 45) , glucagon (7, 37) , the combination of gastrin and glucagon (38, 42) , cholecystokinin (41, 46) , GIP (7), VIP (7), prostaglandins (14, 17, (26) (27) (28) (29) , thyrocalcitonin (47), Pitressin (48) , and acetylcholine (49) (50) (51) . Only in the case of the prostaglandins has the mechanism underlying the secretory response been previously elucidated, and in this instance, stimulation of adenylate cyclase with a re- As is the case with the small intestinal mucosa, it is likely that the effects of VIP on the liver and adipose tissue, and perhaps on the pancreas and heart, are cyclic AMP mediated. Thus, glucagon (57) (58) (59) , secretin (30), and VIP (30) stimulate adenylate cyclase activity in particulate fractions from liver, and all three hormones also stimulate adenylate cyclase in fat cell membranes (30, 31, 60-62). Effects of VIP on myocardial and pancreatic adenylate cyclase have not been reported; the former is activated by glucagon (63, 64) and the latter by secretin (65, 66) . There is reason to believe that VIP and glucagon may interact with separate hormone receptor sites in liver and adipose tissue (30, 67) , while VIP and secretin may activate cyclase via a common receptor in these tissues (30). Repeated attempts in this study and in previous work (14) to demonstrate an effect of either secretin or glucagon on intestinal mucosal cyclic AMP levels or on adenylate cyclase activity in ileal mucosal cell membranes have been unrewarding. These results suggest that the small intestinal mucosal cyclase complex lacks receptors with significant affinities for these peptides. 
